Dr. Stephen E. Gitelman, MD is a renowned pediatric endocrinologist and the director of UCSF's pediatric diabetes program in San Francisco, CA. With a team of experts, he provides comprehensive care to over 800 children, adolescents, and young adults with type 1 and type 2 diabetes, utilizing the latest approaches such as insulin pumps, continuous glucose sensors, and novel insulin analogues. Dr. Gitelman's research focuses on understanding the immune-mediated destruction of insulin-producing beta cells and finding safe and effective ways to alter the natural course of diabetes.
As a distinguished professor at UCSF, Dr. Gitelman completed his medical degree at the University of North Carolina at Chapel Hill and his residency in pediatrics and fellowship in pediatric endocrinology at UCSF. He is actively involved in clinical trials and research networks, including TrialNet and the Immune Tolerance Network, aiming to advance the field of pediatric diabetes care. With his expertise and dedication, Dr. Gitelman is committed to providing world-class care to his patients and contributing to the improvement of pediatric diabetes treatment.
Generated from the website